SCHEMBL4404311

SCHEMBL4404311

Nc1ccc(-c2ccc(=O)n(Cc3cccc(NC(=O)OCCN4CCOCC4)c3)n2)cc1

nearest known ligand 0.72

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 15/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2672982 0.90 MET (0.69) MET
SCHEMBL2673339 0.89 MET (0.75) MET
SCHEMBL2672869 0.89 MET (0.91) MET
SCHEMBL4404447 0.88 MET (0.79) MET
SCHEMBL2672833 0.88 MET (0.79) MET
SCHEMBL2672939 0.87 MET (0.88) MET
SCHEMBL12463380 0.87 MET (0.70) MET
SCHEMBL13247309 0.86 MET (0.69) MET
SCHEMBL2673288 0.84 MET (0.83) MET
SCHEMBL2673105 0.84 MET (1.00) MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173653-B2 Pyridiazinone derivatives for the treatment of tumours MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2012-05-08 — — US disclosed
Send feedback